Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Grauslund

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
BMC Pharmacology|December 4, 2004
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cellsLars H Jensen, Marielle Dejligbjerg, Lasse T Hansen, et al.
Virchows Archiv : an International Journal of Pathology|October 24, 2014
Medullary carcinoma of the colon: can the undifferentiated be differentiated?Anne-Marie Kanstrup Fiehn, Morten Grauslund, Anders Glenthøj, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 30, 2026
Correlation of TP53 Mutations With p53 Expression and Ki-67 Index in Pulmonary Large Cell Neuroendocrine CarcinomasMartin Stampe, Jonas Smidt, Linea Melchior, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contaminationTine Greve, Vera Timmermans Wielenga, Morten Grauslund, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutationEric Santoni-Rugiu, Morten Grauslund, Linea C Melchior, et al.
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Toxicology|January 19, 2010
A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damageAnnemette V Thougaard, Seppo W Langer, Bo Hainau, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 14, 2012
Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?Morten Andersen, Morten Grauslund, Marwa Muhammad-Ali, et al.
Electrophoresis|August 19, 2010
Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostatHans Christian Beck, Jørgen Petersen, Søren Jensby Nielsen, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
BMC Pharmacology|December 4, 2004
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cellsLars H Jensen, Marielle Dejligbjerg, Lasse T Hansen, et al.
Virchows Archiv : an International Journal of Pathology|October 24, 2014
Medullary carcinoma of the colon: can the undifferentiated be differentiated?Anne-Marie Kanstrup Fiehn, Morten Grauslund, Anders Glenthøj, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 30, 2026
Correlation of TP53 Mutations With p53 Expression and Ki-67 Index in Pulmonary Large Cell Neuroendocrine CarcinomasMartin Stampe, Jonas Smidt, Linea Melchior, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2013
Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contaminationTine Greve, Vera Timmermans Wielenga, Morten Grauslund, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutationEric Santoni-Rugiu, Morten Grauslund, Linea C Melchior, et al.
Anticancer Research|October 28, 2015
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural MesotheliomaMorten Andersen, Davide Trapani, Jesper Ravn, et al.
International Journal of Molecular Sciences|July 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced <i>ALK</i>-Rearranged NSCLCEdyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund, et al.
Toxicology|January 19, 2010
A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damageAnnemette V Thougaard, Seppo W Langer, Bo Hainau, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 14, 2012
Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?Morten Andersen, Morten Grauslund, Marwa Muhammad-Ali, et al.
Electrophoresis|August 19, 2010
Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostatHans Christian Beck, Jørgen Petersen, Søren Jensby Nielsen, et al.
Pageof 4